These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22338061)

  • 1. What proportion of vancomycin trough levels are drawn too early?: frequency and impact on clinical actions.
    Morrison AP; Melanson SE; Carty MG; Bates DW; Szumita PM; Tanasijevic MJ
    Am J Clin Pathol; 2012 Mar; 137(3):472-8. PubMed ID: 22338061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
    Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
    Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monitoring of vancomycin in pediatrics].
    Delicourt A; Touzin K; Lavoie A; Therrien R; Lebel D
    Med Mal Infect; 2012 Apr; 42(4):167-70. PubMed ID: 22424794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
    Truong J; Levkovich BJ; Padiglione AA
    Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
    Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
    Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
    Horey A; Mergenhagen KA; Mattappallil A
    Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of elevated trough serum vancomycin concentrations with obesity.
    Richardson J; Scheetz M; O'Donnell EP
    J Infect Chemother; 2015 Jul; 21(7):507-11. PubMed ID: 25851852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia.
    Hochart C; Berthon C; Corm S; Gay J; Cliquennois M; Tricot S; Alfandari S
    Med Mal Infect; 2011 Dec; 41(12):652-6. PubMed ID: 22056376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing the Time of Blood Collection to Determine Vancomycin Concentrations in Intensive Care Unit Patients.
    Hammond DA; James TB; Atkinson LN; Painter JT; Lusardi K
    Crit Care Nurse; 2018 Feb; 38(1):24-28. PubMed ID: 29437075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit.
    Qian X; Du G; Weng C; Zhou H; Zhou X
    Int J Infect Dis; 2017 Jul; 60():17-22. PubMed ID: 28457752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
    Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of a vancomycin loading dose in children.
    Demirjian A; Finkelstein Y; Nava-Ocampo A; Arnold A; Jones S; Monuteaux M; Sandora TJ; Patterson A; Harper MB
    Pediatr Infect Dis J; 2013 Nov; 32(11):1217-23. PubMed ID: 23817340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations.
    Thomson AH; Staatz CE; Tobin CM; Gall M; Lovering AM
    J Antimicrob Chemother; 2009 May; 63(5):1050-7. PubMed ID: 19299472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trough concentration over 12.1 mg/L is a major risk factor of vancomycin-related nephrotoxicity in patients with therapeutic drug monitoring.
    Han HK; An H; Shin KH; Shin D; Lee SH; Kim JH; Cho SH; Kang HR; Jang IJ; Yu KS; Lim KS
    Ther Drug Monit; 2014 Oct; 36(5):606-11. PubMed ID: 24577126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
    Jarkowski A; Forrest A; Sweeney RP; Tan W; Segal BH; Almyroudis N; Wang ES; Wetzler M
    J Oncol Pharm Pract; 2012 Mar; 18(1):91-6. PubMed ID: 21521799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
    Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
    Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring serum vancomycin concentrations in the treatment of Staphylococcus infections in children].
    Mariani-Kurkdjian P; Nebbad H; Aujard Y; Bingen E
    Arch Pediatr; 2008 Nov; 15(11):1625-9. PubMed ID: 18848438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
    Hermsen ED; Hanson M; Sankaranarayanan J; Stoner JA; Florescu MC; Rupp ME
    Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.